These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 15925528)
21. Recruitment of prospective donors: what do they expect from a homepage of a blood transfusion service? Moog R; Fourné K Transfus Med; 2007 Aug; 17(4):279-84. PubMed ID: 17680953 [TBL] [Abstract][Full Text] [Related]
22. The German approach to apheresis guidelines. Kretschmer V Transfus Sci; 1990; 11(3-4):309-11. PubMed ID: 10149531 [No Abstract] [Full Text] [Related]
23. Dr. Jeane Hester: the matriarch of helping to advance therapeutic and donor apheresis medicine and the development of innovative centrifugal apheresis devices. Smith DL Transfus Apher Sci; 2014 Aug; 51(1):4-7. PubMed ID: 25195088 [No Abstract] [Full Text] [Related]
25. Prospective evaluation of double RBC collection using three different apheresis systems. Picker SM; Radojska SM; Gathof BS Transfus Apher Sci; 2006 Dec; 35(3):197-205. PubMed ID: 17097350 [TBL] [Abstract][Full Text] [Related]
26. How free of residual cells and cell antigens is human blood plasma? A comparison of different production methods of human blood plasma and the risk of the products for patients. Wurm K; Rummler S; Barz D Transfus Apher Sci; 2008 Apr; 38(2):149-57. PubMed ID: 18348910 [TBL] [Abstract][Full Text] [Related]
28. Guidelines for the clinical use of blood cell separators. Joint Working Party of the Transfusion and Clinical Haematology Task Forces of the British Committee for Standards in Haematology. Clin Lab Haematol; 1998 Oct; 20(5):265-78. PubMed ID: 9807673 [TBL] [Abstract][Full Text] [Related]
29. [Side effects and risks in cytapheresis donors]. Borberg H; Gaczkowski A; Kadar J; Böhm R Beitr Infusionther Klin Ernahr; 1987; 18():192-8. PubMed ID: 3439972 [No Abstract] [Full Text] [Related]
30. Advanced apheresis course and Fourth National Component Symposium, February 1990. Jacobs P; Wood L Curationis; 1990 Dec; 13(3-4):85-90. PubMed ID: 1982625 [No Abstract] [Full Text] [Related]
31. [Apheresis Techniques]. Mariano M G Ital Nefrol; 2017 Sep; 34(5):73-88. PubMed ID: 28963829 [TBL] [Abstract][Full Text] [Related]
33. Apheresis versus metastasis. Williams M Transfus Apher Sci; 2007 Apr; 36(2):213-4. PubMed ID: 17376743 [No Abstract] [Full Text] [Related]
34. [Method of determining protein-cellular microaggregates in hemotransfusion media and a device for its conduction]. Timchenko NV; Petrov MM Gematol Transfuziol; 1985 Jul; 30(7):54-8. PubMed ID: 4054557 [No Abstract] [Full Text] [Related]
37. Adsorbent: a determinant for the future development of therapeutic apheresis. Akizawa T Ther Apher; 1998 Feb; 2(1):1-2. PubMed ID: 10227781 [No Abstract] [Full Text] [Related]
38. The French approach to donor apheresis guidelines. Calot JP Transfus Sci; 1990; 11(3-4):319-22. PubMed ID: 10149533 [No Abstract] [Full Text] [Related]
39. What's going on in LDL apheresis. Onofrillo D; Accorsi P Transfus Apher Sci; 2007 Dec; 37(3):213-21. PubMed ID: 18054286 [No Abstract] [Full Text] [Related]